Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03281486Not ApplicableCompleted

"Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth

Role: lead

NCT04719091Not ApplicableCompleted

CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA

Role: lead

NCT02992314Not ApplicableCompleted

Determination of the Safety and Effectiveness of an Oral Rinse in the Reduction of Medication Associated Metallic Taste

Role: lead

NCT04197427Not ApplicableUnknown

Determination of the Safety and Efficacy of a Novel Oral Rinse on Oral Health

Role: lead

NCT03295019Not ApplicableUnknown

"Hyaluronan" Formulation for Dry Mouth in Sleep Apnea Patients

Role: lead

All 5 trials loaded